Our Technology

Our biomedical membranes are based on patented nanofiber technology developed by scientists Benjamin Chu, Benjamin Hsiao, and Dufei Fang at Stony Brook University over the past decade with funding support from the National Institutes of Health. This technology allows us to precisely tune our membranes to serve a variety of functions inside the body.

These membranes can be engineered to deliver combination therapies with individualized release profiles, thus enabling a highly functional and adaptable platform for a wide range of applications. The resulting products stemming from this groundbreaking platform technology will represent a true breakthrough in the treatment of many medical conditions.